Eilat Shinar

4.4k total citations
109 papers, 2.4k citations indexed

About

Eilat Shinar is a scholar working on Hematology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Eilat Shinar has authored 109 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hematology, 25 papers in Infectious Diseases and 23 papers in Epidemiology. Recurrent topics in Eilat Shinar's work include Erythrocyte Function and Pathophysiology (17 papers), Blood groups and transfusion (17 papers) and Hemoglobinopathies and Related Disorders (16 papers). Eilat Shinar is often cited by papers focused on Erythrocyte Function and Pathophysiology (17 papers), Blood groups and transfusion (17 papers) and Hemoglobinopathies and Related Disorders (16 papers). Eilat Shinar collaborates with scholars based in Israel, United States and United Kingdom. Eilat Shinar's co-authors include E. A. Rachmilewitz, SL Schrier, EA Rachmilewitz, Mordechai Chevion, O Shalev, Samuel E. Lux, E. A. Rachmilewitz, D. Danon, Eliezer A. Rachmilewitz and Vered Yahalom and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Eilat Shinar

106 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eilat Shinar Israel 27 665 623 489 355 335 109 2.4k
Chris Van Geet Belgium 34 592 0.9× 272 0.4× 1.5k 3.0× 926 2.6× 266 0.8× 145 3.6k
Anne Winkler United States 28 245 0.4× 338 0.5× 438 0.9× 298 0.8× 180 0.5× 73 2.2k
H. Denis Alexander United Kingdom 25 443 0.7× 299 0.5× 232 0.5× 609 1.7× 282 0.8× 71 2.6k
James G. Taylor United States 38 2.2k 3.3× 367 0.6× 1.7k 3.4× 731 2.1× 315 0.9× 132 4.1k
Ricardo Machado Xavier Brazil 37 372 0.6× 486 0.8× 942 1.9× 854 2.4× 399 1.2× 283 5.1k
Roy D. Baynes South Africa 24 868 1.3× 210 0.3× 1.6k 3.2× 207 0.6× 139 0.4× 58 2.5k
Jacques R. Caldwell United States 22 205 0.3× 256 0.4× 276 0.6× 208 0.6× 178 0.5× 38 2.6k
Rodrig Marculescu Austria 31 202 0.3× 311 0.5× 188 0.4× 1.0k 2.9× 537 1.6× 157 3.2k
Alvin M. Mauer United States 36 443 0.7× 440 0.7× 914 1.9× 560 1.6× 376 1.1× 110 4.1k
Erik Waage Nielsen Norway 27 766 1.2× 203 0.3× 462 0.9× 339 1.0× 330 1.0× 139 2.6k

Countries citing papers authored by Eilat Shinar

Since Specialization
Citations

This map shows the geographic impact of Eilat Shinar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eilat Shinar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eilat Shinar more than expected).

Fields of papers citing papers by Eilat Shinar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eilat Shinar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eilat Shinar. The network helps show where Eilat Shinar may publish in the future.

Co-authorship network of co-authors of Eilat Shinar

This figure shows the co-authorship network connecting the top 25 collaborators of Eilat Shinar. A scholar is included among the top collaborators of Eilat Shinar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eilat Shinar. Eilat Shinar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghanem‐Zoubi, Nesrin, et al.. (2024). Cross-Sectional Study of Q Fever Seroprevalence among Blood Donors, Israel, 2021. Emerging infectious diseases. 30(5). 941–946.
2.
Lewin, Antoine, Mindy Goldman, Michael P. Busch, et al.. (2024). End of selection criteria based on sexual orientation: An international symposium on alternatives to donation deferral. Vox Sanguinis. 119(4). 388–401. 7 indexed citations
4.
Talmy, Tomer, Mark H. Yazer, Avi Shina, et al.. (2023). Low‐titer group O whole blood in military ground ambulances: Lessons from the Israel Defense Forces initial experience. Transfusion Medicine. 33(6). 440–452. 2 indexed citations
5.
Blickstein, Dorit, Marina Izak, Naomi Rahimi‐Levene, et al.. (2023). Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID‐19 infection. Vox Sanguinis. 118(7). 517–522. 1 indexed citations
6.
Cohen, Dani, Marina Izak, Evgeniy Stoyanov, et al.. (2023). Predictors of reinfection with pre-Omicron and Omicron variants of concern among individuals who recovered from COVID-19 in the first year of the pandemic. International Journal of Infectious Diseases. 132. 72–79. 9 indexed citations
7.
Rahimi‐Levene, Naomi, Irma Tzur, Victoria Peer, et al.. (2022). Predictors of mortality in COVID-19 patients treated with convalescent plasma therapy. PLoS ONE. 17(7). e0271036–e0271036. 4 indexed citations
8.
Klompus, Shelley, Sigal Leviatan, Thomas Vogl, et al.. (2021). Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers. Science Immunology. 6(61). 30 indexed citations
9.
Radomislensky, Irina, Avishai M. Tsur, Eilat Shinar, et al.. (2021). A prehospital scoring system for predicting the need for emergent blood product transfusion. Transfusion. 61(S1). S195–S205. 7 indexed citations
10.
Zielinski, Martin D., James R. Stubbs, Kathleen S. Berns, et al.. (2017). Prehospital blood transfusion programs. The Journal of Trauma: Injury, Infection, and Critical Care. 82(6S). S70–S78. 48 indexed citations
11.
Anis, Emilia, Alex Leventhal, Paul E. Slater, et al.. (2008). Smallpox revaccination of 21000 first responders in Israel: lessons learned. International Journal of Infectious Diseases. 13(3). 403–409. 3 indexed citations
12.
Sarov, Batia, Lena Novack, Netta Beer, et al.. (2007). Feasibility and cost–benefit of implementing pooled screening for HCVAg in small blood bank settings. Transfusion Medicine. 17(6). 479–487. 12 indexed citations
13.
Sarov, Batia, Lena Novack, Noya Galai, et al.. (2007). Estimation of delay in detecting hepatitis C virus antibodies in pools compared to individual testing on seroconversion panels. Clinical Microbiology and Infection. 13(7). 737–739. 3 indexed citations
14.
Shinar, Eilat, Vered Yahalom, & Barbara Silverman. (2006). Meeting blood requirements following terrorist attacks: the Israeli experience. Current Opinion in Hematology. 13(6). 452–456. 28 indexed citations
15.
Shovman, Ora, Boris Gilburd, Ori Barzilai, et al.. (2005). Evaluation of the BioPlex™ 2200 ANA Screen: Analysis of 510 Healthy Subjects: Incidence of Natural/Predictive Autoantibodies. Annals of the New York Academy of Sciences. 1050(1). 380–388. 99 indexed citations
16.
Kachel, Erez, et al.. (2004). Macrophage suspensions prepared from a blood unit for treatment of refractory human ulcers. Transfusion and Apheresis Science. 30(2). 163–167. 35 indexed citations
17.
Shamir, Raanan, Aaron Lerner, Eilat Shinar, et al.. (2002). The use of a single serological marker underestimates the prevalence of celiac disease in Israel: a study of blood donors. The American Journal of Gastroenterology. 97(10). 2589–2594. 103 indexed citations
18.
Halle, David, et al.. (2001). High prevalence of complement C7 deficiency among healthy blood donors of Moroccan Jewish ancestry. American Journal of Medical Genetics. 99(4). 325–327. 16 indexed citations
19.
Shinar, Eilat & Eliezer A. Rachmilewitz. (1990). Differences in the Pathophysiology of Hemolysis of α‐ and β‐Thalassemic Red Blood Cells. Annals of the New York Academy of Sciences. 612(1). 118–126. 15 indexed citations
20.
Engelhard, Dan, et al.. (1989). Combined therapy with granulocyte transfusion, intravenous opsonins and antibiotics for overwhelming Pseudomonas aeruginosa septicemia in neutropenic cancer patients.. PubMed. 8(5). 332–4. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026